Selected research
Market Structure
Global PRP (Platelet-Rich Plasma) Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global PRP (Platelet-Rich Plasma) Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for PRP (Platelet-Rich Plasma) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of PRP (Platelet-Rich Plasma) Kits include AdvaCare Pharma, Companion (Enovis), Dr. PRP USA, EmCyte, Enso Discoveries, Estar Medical, Fidia Farmaceutici, Juventix Regenerative Medical and Plasma Fresh, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global PRP (Platelet-Rich Plasma) Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of PRP (Platelet-Rich Plasma) Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents PRP (Platelet-Rich Plasma) Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PRP (Platelet-Rich Plasma) Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
PRP (Platelet-Rich Plasma) Kits Segment by Company
AdvaCare Pharma
Companion (Enovis)
Dr. PRP USA
EmCyte
Enso Discoveries
Estar Medical
Fidia Farmaceutici
Juventix Regenerative Medical
Plasma Fresh
PRP PURE
Refine USA
Regen Lab SA
Beijing Hanbaihan Medical Devices
Beijing Chunlizhengda Medical Instruments
Longtime Biological
WEGO
PRP (Platelet-Rich Plasma) Kits Segment by Type
Class II Medical Device
Class I Medical Device
PRP (Platelet-Rich Plasma) Kits Segment by Application
Medical
Laboratory
Others
PRP (Platelet-Rich Plasma) Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PRP (Platelet-Rich Plasma) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PRP (Platelet-Rich Plasma) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PRP (Platelet-Rich Plasma) Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the PRP (Platelet-Rich Plasma) Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PRP (Platelet-Rich Plasma) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PRP (Platelet-Rich Plasma) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of PRP (Platelet-Rich Plasma) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Class II Medical Device
- Class I Medical Device
Applications
- Medical
- Laboratory
- Others
Companies covered
- AdvaCare Pharma
- Companion (Enovis)
- Dr. PRP USA
- EmCyte
- Enso Discoveries
- Estar Medical
- Fidia Farmaceutici
- Juventix Regenerative Medical
- Plasma Fresh
- PRP PURE
- Refine USA
- Regen Lab SA
- Beijing Hanbaihan Medical Devices
- Beijing Chunlizhengda Medical Instruments
- Longtime Biological
- WEGO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global PRP (Platelet-Rich Plasma) Kits Market Size, 2021 VS 2025 VS 2032
- 1.3 Global PRP (Platelet-Rich Plasma) Kits Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global PRP (Platelet-Rich Plasma) Kits Sales Estimates and Forecasts (2021-2032)
- 1.5 Global PRP (Platelet-Rich Plasma) Kits Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global PRP (Platelet-Rich Plasma) Kits Market Dynamics
- 2.1 PRP (Platelet-Rich Plasma) Kits Industry Trends
- 2.2 PRP (Platelet-Rich Plasma) Kits Industry Drivers
- 2.3 PRP (Platelet-Rich Plasma) Kits Industry Opportunities and Challenges
- 2.4 PRP (Platelet-Rich Plasma) Kits Industry Restraints
3 PRP (Platelet-Rich Plasma) Kits Market by Manufacturers
- 3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Manufacturers (2021-2026)
- 3.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Manufacturers (2021-2026)
- 3.3 Global PRP (Platelet-Rich Plasma) Kits Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global PRP (Platelet-Rich Plasma) Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global PRP (Platelet-Rich Plasma) Kits Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global PRP (Platelet-Rich Plasma) Kits Manufacturers, Product Type & Application
- 3.7 Global PRP (Platelet-Rich Plasma) Kits Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global PRP (Platelet-Rich Plasma) Kits Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 PRP (Platelet-Rich Plasma) Kits Players Market Share by Revenue in 2025
- 3.8.3 2025 PRP (Platelet-Rich Plasma) Kits Tier 1, Tier 2, and Tier 3
4 PRP (Platelet-Rich Plasma) Kits Market by Type
- 4.1 PRP (Platelet-Rich Plasma) Kits Type Introduction
- 4.1.1 Class II Medical Device
- 4.1.2 Class I Medical Device
- 4.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Type
- 4.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Type (2021-2032)
- 4.2.3 Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Type (2021-2032)
- 4.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type
- 4.3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Type (2021-2032)
- 4.3.3 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Type (2021-2032)
5 PRP (Platelet-Rich Plasma) Kits Market by Application
- 5.1 PRP (Platelet-Rich Plasma) Kits Application Introduction
- 5.1.1 Medical
- 5.1.2 Laboratory
- 5.1.3 Others
- 5.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Application
- 5.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Application (2021-2032)
- 5.2.3 Global PRP (Platelet-Rich Plasma) Kits Sales Market Share by Application (2021-2032)
- 5.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application
- 5.3.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Application (2021-2032)
- 5.3.3 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Application (2021-2032)
6 Global PRP (Platelet-Rich Plasma) Kits Sales by Region
- 6.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global PRP (Platelet-Rich Plasma) Kits Sales by Region (2021-2032)
- 6.2.1 Global PRP (Platelet-Rich Plasma) Kits Sales by Region (2021-2026)
- 6.2.2 Global PRP (Platelet-Rich Plasma) Kits Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region
- 7.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region
- 7.1.1 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2021-2026)
- 7.1.3 Global PRP (Platelet-Rich Plasma) Kits Revenue by Region (2027-2032)
- 7.1.4 Global PRP (Platelet-Rich Plasma) Kits Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
- 7.2.2 North America PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
- 7.3.2 Europe PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
- 7.4.2 Asia-Pacific PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa PRP (Platelet-Rich Plasma) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 AdvaCare Pharma
- 8.1.1 AdvaCare Pharma Company Information
- 8.1.2 AdvaCare Pharma Business Overview
- 8.1.3 AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 AdvaCare Pharma PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.1.5 AdvaCare Pharma Recent Developments
- 8.2 Companion (Enovis)
- 8.2.1 Companion (Enovis) Company Information
- 8.2.2 Companion (Enovis) Business Overview
- 8.2.3 Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Companion (Enovis) PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.2.5 Companion (Enovis) Recent Developments
- 8.3 Dr. PRP USA
- 8.3.1 Dr. PRP USA Company Information
- 8.3.2 Dr. PRP USA Business Overview
- 8.3.3 Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dr. PRP USA PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.3.5 Dr. PRP USA Recent Developments
- 8.4 EmCyte
- 8.4.1 EmCyte Company Information
- 8.4.2 EmCyte Business Overview
- 8.4.3 EmCyte PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 EmCyte PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.4.5 EmCyte Recent Developments
- 8.5 Enso Discoveries
- 8.5.1 Enso Discoveries Company Information
- 8.5.2 Enso Discoveries Business Overview
- 8.5.3 Enso Discoveries PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Enso Discoveries PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.5.5 Enso Discoveries Recent Developments
- 8.6 Estar Medical
- 8.6.1 Estar Medical Company Information
- 8.6.2 Estar Medical Business Overview
- 8.6.3 Estar Medical PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Estar Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.6.5 Estar Medical Recent Developments
- 8.7 Fidia Farmaceutici
- 8.7.1 Fidia Farmaceutici Company Information
- 8.7.2 Fidia Farmaceutici Business Overview
- 8.7.3 Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Fidia Farmaceutici PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.7.5 Fidia Farmaceutici Recent Developments
- 8.8 Juventix Regenerative Medical
- 8.8.1 Juventix Regenerative Medical Company Information
- 8.8.2 Juventix Regenerative Medical Business Overview
- 8.8.3 Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Juventix Regenerative Medical PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.8.5 Juventix Regenerative Medical Recent Developments
- 8.9 Plasma Fresh
- 8.9.1 Plasma Fresh Company Information
- 8.9.2 Plasma Fresh Business Overview
- 8.9.3 Plasma Fresh PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Plasma Fresh PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.9.5 Plasma Fresh Recent Developments
- 8.10 PRP PURE
- 8.10.1 PRP PURE Company Information
- 8.10.2 PRP PURE Business Overview
- 8.10.3 PRP PURE PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 PRP PURE PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.10.5 PRP PURE Recent Developments
- 8.11 Refine USA
- 8.11.1 Refine USA Company Information
- 8.11.2 Refine USA Business Overview
- 8.11.3 Refine USA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Refine USA PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.11.5 Refine USA Recent Developments
- 8.12 Regen Lab SA
- 8.12.1 Regen Lab SA Company Information
- 8.12.2 Regen Lab SA Business Overview
- 8.12.3 Regen Lab SA PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Regen Lab SA PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.12.5 Regen Lab SA Recent Developments
- 8.13 Beijing Hanbaihan Medical Devices
- 8.13.1 Beijing Hanbaihan Medical Devices Company Information
- 8.13.2 Beijing Hanbaihan Medical Devices Business Overview
- 8.13.3 Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Beijing Hanbaihan Medical Devices PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.13.5 Beijing Hanbaihan Medical Devices Recent Developments
- 8.14 Beijing Chunlizhengda Medical Instruments
- 8.14.1 Beijing Chunlizhengda Medical Instruments Company Information
- 8.14.2 Beijing Chunlizhengda Medical Instruments Business Overview
- 8.14.3 Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Beijing Chunlizhengda Medical Instruments PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.14.5 Beijing Chunlizhengda Medical Instruments Recent Developments
- 8.15 Longtime Biological
- 8.15.1 Longtime Biological Company Information
- 8.15.2 Longtime Biological Business Overview
- 8.15.3 Longtime Biological PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Longtime Biological PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.15.5 Longtime Biological Recent Developments
- 8.16 WEGO
- 8.16.1 WEGO Company Information
- 8.16.2 WEGO Business Overview
- 8.16.3 WEGO PRP (Platelet-Rich Plasma) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 WEGO PRP (Platelet-Rich Plasma) Kits Product Portfolio
- 8.16.5 WEGO Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 PRP (Platelet-Rich Plasma) Kits Value Chain Analysis
- 9.1.1 PRP (Platelet-Rich Plasma) Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 PRP (Platelet-Rich Plasma) Kits Production Mode & Process
- 9.2 PRP (Platelet-Rich Plasma) Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 PRP (Platelet-Rich Plasma) Kits Distributors
- 9.2.3 PRP (Platelet-Rich Plasma) Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst